Velcade (bortezomib) for injection therapy for early relapsed prostate cancer.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Bortezomib (Primary) ; Bicalutamide; Flutamide; Goserelin; Leuprorelin
- Indications Prostate cancer
- Focus Therapeutic Use
- 17 Oct 2018 Status changed to discontinued due to low accrual
- 27 Apr 2012 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 27 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.